A novel estetrol-containing combined oral contraceptive: European expert panel review.

Kristina Gemzell-Danielsson Angelo Cagnacci Nathalie Chabbert-Buffet Jonathan Douxfils Jean Michel Foidart Ali Kubba Luis Ignacio Lete LasaDiana MansourJoseph NeulenJaoquim NevesFátima Palma Thomas Römer Robert Z SpaczynskiVera Tóth

Published in: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception (2022)

E4 15 mg/DRSP 3 mg provides safe and effective contraception, with high user satisfaction and predictable bleeding. Further research will evaluate the long-term safety of the COC.

Keyphrases

atrial fibrillation